YSA-33815-37867
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 028 / RI
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Pfizer-BioNTech
-
2021-02-22
Registered in v-safe
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
-
2021-03-13
Dose 2 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches · Be unable to workAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-22
- 2021-03-29
- 2021-04-12
- 2021-04-17
- 2021-04-26
- 2021-06-14
-
2021-08-21
Dose 3 — Pfizer-BioNTech
- 2021-08-21
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-08-28
- 2021-09-04
- 2021-09-11
- 2021-09-19
- 2021-09-25
- 2021-10-02
- 2021-11-20
- 2022-02-20
-
2022-08-21
Survey response — 12 months, dose 3MedDRA: COVID-19, Pneumonia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Pneumonia. CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-08-21
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-08-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Pfizer-BioNTech | |
| 2 | 2021-03-13 | Pfizer-BioNTech | |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-21 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Pneumonia. Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release